Socioeconomic Status and Determinants of Pediatric Antibiotic Use

Andrew McGurn1, Brittany Watchmaker2, Kaavya Adam3

  • 1Rush University Medical Center, Chicago, IL, USA.

Clinical Pediatrics
|August 5, 2020
PubMed

Insights

Early antibiotic exposure in children may be linked to socioeconomic status (SES). Children from high-poverty areas received fewer prescriptions overall but were more likely to receive antibiotics within the first week of life.

Area of Science:

  • Pediatric Health
  • Public Health
  • Microbiome Research

Background:

  • Early-life antibiotic exposure is linked to altered gut microbiome and increased obesity risk.
  • The obesity epidemic disproportionately affects individuals from lower socioeconomic status (SES).

Purpose of the Study:

  • To investigate the association between socioeconomic status and antibiotic use in early childhood.
  • To understand potential drivers of health disparities in childhood obesity.

Main Methods:

  • Retrospective cohort study of 7224 infants born between 2007-2017 in a suburban Illinois health system.
  • Used zip code as a proxy for SES and analyzed antibiotic prescriptions in the first year of life.
  • Collected data on comorbidities, race/ethnicity, gender, and healthcare utilization.

Main Results:

  • Children from high-poverty areas showed a trend towards fewer overall antibiotic prescriptions.
  • Infants from high-poverty areas were significantly more likely to receive antibiotics within the first week of life, even after adjusting for covariates.
  • Unadjusted analyses indicated higher early antibiotic use in high-poverty areas at 48 hours, 1 week, and 1 month, but significance was lost after covariate adjustment.

Conclusions:

  • The relationship between SES and early-life antibiotic use requires further investigation.
  • Understanding this link may help address health disparities in childhood obesity within low-income communities.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
175
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
153
Antibiotic Selection00:57

Antibiotic Selection

Overview
58.8K